News

Eli Lilly's Orforglipron shines in Phase III trials, potentially leading diabetes and obesity treatment by 2026. See what to ...
Evie, now 19, experienced eight different symptoms in the lead-up to being diagnosed with Hodgkin lymphoma, a type of blood ...